Free Trial
→ Warning: Elon’s $20k Robot Might Replace Your Nanny (From WealthPress) (Ad)

Zynex Q4 2022 Earnings Report

Zynex logo
$7.44 +0.02 (+0.27%)
As of 04:00 PM Eastern
Earnings HistoryForecast

Zynex EPS Results

Actual EPS
$0.20
Consensus EPS
$0.19
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Zynex Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Zynex Announcement Details

Quarter
Q4 2022
Date
3/14/2023
Time
N/A

Conference Call Resources

Zynex Earnings Headlines

Zynex (ZYXI) to Release Earnings on Wednesday
February 24 at 3:29 AM | americanbankingnews.com
Contrasting Zynex (NASDAQ:ZYXI) & Endonovo Therapeutics (OTCMKTS:ENDV)
February 17, 2025 | americanbankingnews.com
30-year market phenomenon opens up overnight opportunity
We get a chance to target these overnight returns up to FOUR times each week. Now, there would have been smaller wins and those that did not work out and I can’t promise future returns or guarantee against losses… But this is a new way for everyday folks to target a couple hundred bucks or more nearly every single day the markets are open… Regardless of which way the markets are headed… Up, down or FLAT! And now… We can target MORE payouts in LESS time! It’s a total game-changer…
February 27, 2025 | ProsperityPub (Ad)
With 47% ownership, Zynex, Inc. (NASDAQ:ZYXI) insiders have a lot at stake
February 13, 2025 | finance.yahoo.com
Zynex removed from TRICARE Network, The Capitol Forum reports
February 8, 2025 | markets.businessinsider.com
Zynex eyes FDA submission for NiCO oximeter as it expands portfolio of innovative medical devices
January 28, 2025 | proactiveinvestors.com
See More Zynex Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Zynex? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zynex and other key companies, straight to your email.

About Zynex

Zynex (NASDAQ:ZYXI), together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

View Zynex Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles